Article Text

Download PDFPDF
Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay
  1. R E Biagini1,
  2. D L Sammons1,
  3. J P Smith1,
  4. E H Page2,
  5. J E Snawder1,
  6. C A F Striley1,
  7. B A MacKenzie1
  1. 1Division of Applied Research and Technology, National Institute for Occupational Safety and Health, Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, 4676 Columbia Parkway, Cincinnati, OH 45226, USA
  2. 2Division of Surveillance, Hazard Evaluation and Field Studies, National Institute for Occupational Safety and Health, Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, 4676 Columbia Parkway, Cincinnati, OH 45226, USA
  1. Correspondence to:
 Dr R E Biagini
 Director Research Scientist, Division of Applied Research and Technology, Biomonitoring and Health Assessment Branch, Biological Monitoring Laboratory Section, CDC/NIOSH MS C-26, Robert A. Taft Laboratories, 4676 Columbia Parkway, Cincinnati, OH 45226, USA; rbiaginicdc.gov

Abstract

Aims: To evaluate potential exposure to Bacillis anthracis (Ba) spores in sampling/decontamination workers in the aftermath of an anthrax terror attack.

Methods: Fifty six serum samples were obtained from workers involved in environmental sampling for Ba spores at the American Media, Inc. (AMI) building in Boca Raton, FL after the anthrax attack there in October 2001. Nineteen sera were drawn from individuals both pre-entry and several weeks after entrance into the building. Nine sera each were drawn from unique individuals at the pre-entry and follow up blood draws. Thirteen donor control sera were also evaluated. Individuals were surveyed for Ba exposure by measurement of serum Ba anti-protective antigen (PA) specific IgG antibodies using a newly developed fluorescent covalent microsphere immunoassay (FCMIA).

Results: Four sera gave positive anti-PA IgG results (defined as anti-PA IgG concentrations ⩾ the mean μg/ml anti-PA IgG from donor control sera (n = 13 plus 2 SD which were also inhibited ⩾ 85% when the serum was pre-adsorbed with PA). The positive sera were the pre-entry and follow up samples of two workers who had received their last dose of anthrax vaccine in 2000.

Conclusion: It appears that the sampling/decontamination workers of the present study either had insufficient exposure to Ba spores to cause the production of anti-PA IgG antibodies or they were exposed to anthrax spores without producing antibody. The FCMIA appears to be a fast, sensitive, accurate, and precise method for the measurement of anti-PA IgG antibodies.

  • AMI, American Media, Inc
  • AVA, anthrax vaccine adsorbed
  • Ba, Bacillus anthracis
  • FCMIA, fluorescent covalent microsphere immunoassay
  • MDC, minimum detectable concentration
  • MFI, median fluorescence intensity
  • PA, protective antigen
  • PPE, personal protective equipment
  • RDL, reliable detection limit
  • anthrax protective antigen
  • decontamination workers
  • ELISA
  • Luminex

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes